Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 30th June 2024. 2) Consideration of acquisition of an unlisted company in the specialty chemicals sector with a global footprint. 3) Authorise the board to approve the transaction structure valuation and timelines given the preliminary nature of the discussions. 4) Ratify the transaction in a subsequent Extraordinary General Meeting (EGM) or through Postal Ballot.